Related Experiment Video
Updated: May 15, 2026

07:31
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
The new risk adjustment formula in Germany: implementation and first experiences.
Florian Buchner1, Dirk Goepffarth, Juergen Wasem
1Carinthia University of Applied Sciences, Universität Duisburg-Essen, Germany.
Health Policy (Amsterdam, Netherlands)
|January 2, 2013
Summary
Germany
Area of Science:
- Health Economics
- Public Health Policy
- Healthcare Regulation
Background:
- Germany's sickness fund competition relies on risk adjustment to ensure fairness among funds with diverse patient populations.
- The previous demographic model was replaced in 2009 by a morbidity-based system.
- This system incorporates 80 severe or chronic diseases within a hierarchical structure.
Purpose of the Study:
- To evaluate the performance of Germany's 2009 morbidity-based risk adjustment system.
- To compare the new system's effectiveness against the prior demographic model.
- To identify areas for improvement in the risk adjustment formula.
Main Methods:
- Evaluation based on 2009 data, the first year of the new system's implementation.
- Analysis of individual and group-level performance metrics.
- Joint analysis of coding and prescription patterns to assess behavioral changes.
Main Results:
- Significant improvements in individual and group-level performance compared to the old model.
- Enhanced predictive accuracy at the sickness fund level.
- No discernible changes in coding or prescription behavior attributable to the new system.
Conclusions:
- The 2009 morbidity-based risk adjustment system demonstrates improved performance and predictive accuracy.
- Identified issues include underpayment for older populations and multi-morbidity, and overpayment for those without conditions.
- Further refinements are needed to address age-related and multi-morbidity payment disparities.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Relative Risk
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
Actuarial Approach
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Kaplan-Meier Approach
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
